Sensory Medical, a medical device company focused on a new treatment for restless legs syndrome has announced the closing of a $2.5 million series A financing.
Subscribe to our email newsletter
Salt Creek Medical Device Development (Salt Creek Medical), a medical device company ‘generator’, provided all of the financing through its venture fund, Salt Creek Fund I. The company will use the funds to launch an FDA clinical study on a new device for treatment of restless legs syndrome.
In connection with the series A financing, Jim Voelker, advisor to the Salt Creek Fund I and chairman, CEO and president of InfoSpace, will join Sensory Medical’s board of directors.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.